Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Determination of the impurities in drug products containing montelukast and in silico/in vitro genotoxicological assessments of sulfoxide impurity.

Toxicology letters - 14 Oct 2015

Emerce Esra, Cok Ismet, Degim I Tuncer

Abstract excerpt

Impurities affecting safety, efficacy, and quality of pharmaceuticals are of increasing concern for regulatory agencies and pharmaceutical industries, since genotoxic impurities are understood to play important role in carcinogenesis. The study aimed to analyse impurities of montelukast chronically used in asthma theraphy and perform genotoxicological assessment considering regulatory approaches. Impurities...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetates
Share to Anti-Asthmatic Agents
Share to Chemistry, Pharmaceutical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclopropanes

Share to Drug Contamination

Share to Mitotic Index

Share to Quinolines

Share to Sulfides

Source

Identifiers

PMID: 26205398
DOI: 10.1016/j.toxlet.2015.07.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Determination of the impurities in drug products containing montelukast and in silico/in vitro genotoxicological assessments of sulfoxide impurity.PMID 26205398Read ↗

In silico and in vitro genotoxicity evaluation of levofloxacin n-oxide, an impurity in levofloxacin.Semantic proximity Read ↗

The genetic toxicology of paracetamol and aspirin: a review.Semantic proximity Read ↗

Toxicity evaluation of main zopiclone impurities based on quantitative structure-activity relationship models and in vitro tests.Semantic proximity Read ↗

[Genotoxicity tests as a safety study required for the development of pharmaceuticals].Semantic proximity Read ↗

Evaluation of the genotoxic potential of dietary metabolites to support the renewal of an active substance under European Commission Regulation (EC) 1107/2009 – fludioxonil case studySemantic proximity Read ↗

Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines.Semantic proximity Read ↗

Matrine and Oxymatrine: evaluating the gene mutation potential using in silico tools and the bacterial reverse mutation assay (Ames test).Semantic proximity Read ↗

Bacterial mutagenicity screening in the pharmaceutical industry.Semantic proximity Read ↗

Mutagenic and Genotoxic Effect of HydroxyureaSemantic proximity Read ↗

Toxicological assessment of furocoumarins in foodstuffs.Semantic proximity Read ↗

Pharmacokinetic and toxicological aspects of potassium sorbate food additive and its constituentsSemantic proximity Read ↗

Mutagenicity in a Molecule: Identification of Core Structural Features of Mutagenicity Using a Scaffold AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.